---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "4HvfTBkmZx4nQcpsHA2LaNOTPEp7WUiz1ff4d6sqD2rX+atBNDq7sCnMT1ALIy/+mwQKSmXXUQXgkn2tR7Og1XQPri9udqeS3CPsOpBsnxEdtvspZV4SU4xL/BsUer7Eu/eM2N3Zsu8lWL7OuiuuyePdY6WyTA4cmy1WKhvQ8tLT/O2rW024CFd/Yv60kjG4vlexvcwnn3V1ppOCWvdL/pazcJId1UJio5v5IkJg3NfhbugF4iI7mEFO6BWjAqtQNUJ28rM11bCl6kQl1bv1xcaN4d7AYCANTgMJnTsX6ITTcDw0Quc5a+8j3/PWaniEmFIBMSsxZRwc84iq00WlO7lomeJXolJ7BK6r9o3d5vc=;axlodi1JVd4L1oBNrkXLYA=="
---

